This webinar will provide strategies to meaningfully establish two-way engagement between FDA and industry. These channels include communication between regulatory professionals in both formal and informal settings—advisory committees, workshops, webinars, and patient engagement listening sessions, as well as the formal meeting opportunities. Panelists will use practical examples to illustrate how to effectively engage with FDA and address issues in different FDA-regulated product areas using these available channels, as well as how to best utilize the Ombudsman offices, and how to appeal agency decisions within the agency, through citizen petitions, and in court.
Jessica L. Zeller, Vice President, Quality, Regulatory & Public Affairs Counsel, Edwards Life Sciences
Lowell M. Zeta, Partner, Hogan Lovells US LLP
Internet Explorer and Microsoft Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.